Company Filing History:
Years Active: 2025
Title: Xiuli Jin: Innovator in Antibody Therapeutics
Introduction
Xiuli Jin is a prominent inventor based in Beijing, China. She has made significant contributions to the field of biopharmaceuticals, particularly in the development of therapeutic antibodies. Her work focuses on innovative solutions for treating diseases related to PD-L1, a protein that plays a crucial role in immune response.
Latest Patents
Xiuli Jin holds a patent for an "Anti-PD-L1 antibody and use thereof." This patent describes an isolated antibody or antigen-binding fragment that specifically binds to the human PD-L1 protein. The invention includes a nucleic acid molecule encoding the antibody, therapeutic compositions, and their application in treating PD-L1 related diseases, such as tumors that are PD-L1 positive. This patent represents a significant advancement in cancer therapy.
Career Highlights
Xiuli Jin is associated with Beijing Sinotau Bio-pharmaceuticals Technology Co., Ltd., where she continues to drive innovation in antibody research. Her expertise and dedication have positioned her as a key figure in the biopharmaceutical industry.
Collaborations
She collaborates with notable colleagues, including Tong Zhou and Fengqi Cao, who contribute to her research efforts and the advancement of their projects.
Conclusion
Xiuli Jin's work exemplifies the impact of innovative research in the field of biopharmaceuticals. Her contributions to antibody therapeutics are paving the way for new treatment options for patients with PD-L1 related diseases.